Guided Therapeutics, Inc. (OTCQB: GTHP) announced today that it has received an order and payment for a third LuViva® Advanced Cervical Scan and 500 single-use disposable cervical guides for Bulgaria. “We are very excited about this growing market in Eastern Europe...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has reached a licensing agreement with Shenghuo Medical, LLC, for exclusive sales and manufacturing rights...
Guided Therapeutics, Inc. (OTCQB:GTHP) today announced its operating results for the first quarter ended March 31, 2016. Sales Revenue, Cost of Sales and Gross Profit (Loss) from Devices and Disposables: Sales revenue from the sale of LuViva devices and disposables...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today shipment of the first LuViva® Advanced Cervical Scan for the Dominican Republic. “The women of Latin America,...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today released the following letter to shareholders. Dear Fellow Shareholders, Thank you for your support of Guided Therapeutics...
Guided Therapeutics, Inc. (OTCQB: GTHPD), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that the company is shipping its largest ever order of single-use disposable Cervical Guides for use with the...
